OncoCyte Corp.

$OCX is leading the Prism MarketView MedDevices index currently. Earlier today the company announced its renaming and relocation of its principal executive office from Irvine, California, to Nashville, Tennessee. The name change will be Insight Molecular Diagnostics Inc. and have a NASDAQ ticker symbol of ($IMDX)

Share this article:

About the Author:

OncoCyte Corp.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup